TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14747 · May 25

#python#deep_learning#intel#machine_learning#neural_network#pytorch#quantization Intel Extension for PyTorch boosts the speed of PyTorch on Intel hardware, including both CPUs and GPUs, by using special features like AVX-512, AMX, and XMX for faster calculations[5][2][4]. It supports many popular large language models (LLMs) such as Llama, Qwen, Phi, and DeepSeek, offering optimizations for different data types and easy GPU acceleration. This means you can run advanced AI models much faster and more efficiently on your Intel computer, with simple setup and support for both ready-made and custom models. https://github.com/intel/intel-extension-for-pytorch

Results

3 similar posts found

Search: #genetherapy

当前筛选 #genetherapy清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3846 · 01/11/2025, 10:00 AM

Funding Rounds Boost Healthcare & Energy Sectors Several companies have recently secured significant funding: - Arizona Public Service: $1.81B, Jan 8, 2025. - Nephron Pharmaceuticals: $350M, Jan 10, 2025. - Windward Bio: $200M, Jan 10, 2025. - Timberlyne Therapeutics: $180M, Jan 10, 2025. - Hippocratic AI: $141M, Jan 9, 2025. - Ouro Medicines: $120M, Jan 10, 2025. - Movement Labs: $100M, Jan 8, 2025. - Rhygaze: $86M, Jan 10, 2025. - Light Horse Therapeutics: $62M, Jan 9, 2025. - Overhaul: $55M, Jan 10, 2025. - Numab: $54.94M, Jan 9, 2025. - Harsoria Healthcare: $20M, Jan 9, 2025. - Huazhi Energy: $13.64M, Jan 8, 2025. - Lava Network: $12M, Jan 9, 2025. - Pakistan Refinery Ltd: $11.24M, Jan 8, 2025. Find detailed updates on respective company websites for more insights. #Funding#Healthcare#Biotech#Energy#Pharmaceuticals#AI#Tech#GeneTherapy#Blockchain#VentureCapital#Investment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 12/18/2024, 12:11 PM

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform